A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway | |
Gong Chenyuan[1]; Xu Chong[2]; Ji Lili[3]; Wang Zhengtao[4] | |
刊名 | Bioscience trends
![]() |
2013 | |
卷号 | 7页码:230-6 |
ISSN号 | 1881-7823 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2290591 |
专题 | 上海大学 |
作者单位 | The MOE Key Laboratory for Standardization of Chinese Medicines and The Shanghai Key Laboratory for Compound Chinese medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China. |
推荐引用方式 GB/T 7714 | Gong Chenyuan[1],Xu Chong[2],Ji Lili[3],et al. A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway[J]. Bioscience trends,2013,7:230-6. |
APA | Gong Chenyuan[1],Xu Chong[2],Ji Lili[3],&Wang Zhengtao[4].(2013).A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway.Bioscience trends,7,230-6. |
MLA | Gong Chenyuan[1],et al."A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway".Bioscience trends 7(2013):230-6. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论